Forgot your password?
The phase 2 SCOPE study will evaluate the needle-free injection in patients with advanced unresectable cases of the disease
Researchers looked a naturally occurring peptide that regulates inflammation
Approximately 30% of psoriasis patients are affected by psoriatic arthritis
More than 26 million people in the US are affected by the inflammatory skin disease
The event brought together a broad range of experts and clinicians from across the world
KRP-M223 is being developed for CSU and other allergic and inflammatory diseases
Up to 20% of children and 10% of adults globally are affected by the skin disease
The immune-mediated skin disease impacts over 125 million people worldwide
The Stelara biosimilar has been authorised to treat plaque psoriasis and psoriatic arthritis
At least 100 million people worldwide are affected by some form of psoriasis